- Target
- MAGE-C1
- Reactivity
- Human,
- Application
- IHC,WB,IF,ELISA
- MW(Calculated)
- 124kD
- MW(Observed)
- 180kD
- Host Species
- Mouse
- Isotype
- IgG2b,Kappa
- Conjugate/Modification
- Unmodified
- Modification site
- --
- Recommended Dilution Ratio
- IHC 1:200-1000;WB 1:500-2000;IF 1:100-500;ELISA 1:1000-5000
- Form
- PBS, 50% glycerol, 0.05% Proclin 300, 0.05%BSA
- Source
- --
- Purification
- Protein G
- Purity
- --
- storageCondition
- -15°C to -25°C/1 year(Do not lower than -25°C)
- Concentration
- --
- Clonality
- Monoclonal
- Clone No.
- ABT251
- Immunogen
- Synthesized peptide derived from human MAGE-C1 AA range: 700-800
- Sequence
- --
- Specificity
- The antibody can specifically recognize human MAGE-C1 protein.
- Gene Name
- MAGEC1
- Protein Name
- MAGE-C1
- Other Name
- Cancer/testis antigen 7.1;Cancer/testis antigen family 7 member 1;CT7;CT7.1;MAGC1_HUMAN;MAGE C1;MAGE C1 antigen;MAGE-C1 antigen;MAGEC1;melanoma antigen family C, 1;Melanoma associated antigen C1;Melanoma-associated antigen C1;MGC39366
- Organism-1
- Human
- Gene ID-1
- 9947
- SwissProt-1
- O60732
- Organism-2
- --
- Gene ID-2
- --
- SwissProt-2
- --
- Organism-3
- --
- Gene ID-3
- --
- SwissProt-3
- --
- Organism-4
- --
- gene ID-4
- --
- SwissProt-4
- --
- Cellular Localization
- Cytoplasmic